A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 31/00 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61P 27/00 (2006.01)
Patent
CA 2314571
Methods for the prevention and treatment of diseases and conditions of the eye including, but are not limited to: central retinal artery occlusion; central retinal vein occlusion; optic neuropathy including, but not limited to, anterior ischemic optic neuropathy and glaucomatous optic neuropathy; and macular (dry) degeneration are disclosed. These methods comprise administering to a patient a prophylactically or therapeutically effective amount of a cyclic guanosine 3',5'-monophosphate phosphodiesterase type 5 inhibitor. Pharmaceutical compositions and dosage forms comprising cyclic guanosine 3',5'-monophosphate phosphodiesterase type 5 inhibitors are also disclosed.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Methods and compositions for treating diseases and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating diseases and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating diseases and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1408172